Cerenome
CNSY
22 hedge funds and large institutions have $2.89M invested in Cerenome in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 10 closing their positions.
715% more capital inflows, than outflows
Capital inflows: $1.88M | Capital outflows: $231K
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
4.27% more ownership
Funds ownership: 5.33% → 9.6% (+4.3%)
4% less funds holding
Funds holding: 23 → 22 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$1.13M |
| 2 |
Ashton Thomas Private Wealth
Scottsdale,
Arizona
|
+$180K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$140K |
| 4 |
BlackRock
New York
|
+$136K |
| 5 |
Virtu Financial
New York
|
+$83.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
-$52.8K |
| 2 |
Millennium Management
New York
|
-$44.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$24.5K |
| 4 |
Two Sigma Securities
New York
|
-$23.2K |
| 5 |
Citigroup
New York
|
-$20.2K |
CNSY Hedge Fund Activity: Q2 2026 in Review
22 of the 8,376 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q2 2026, worth a combined $2.89M — up 94% from $1.49M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CNSY and 9 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 8 added.
The largest buyer was Vanguard Capital Management, adding an estimated $1.13M. The largest seller was Vanguard Fiduciary Trust, cutting an estimated $52.8K.
- 22 institutional investors held Cerenome (CNSY) as of Q2 2026, down from 23 in Q1 2026.
- Funds reported $2.89M of Cerenome stock for Q2 2026, up 94% quarter-over-quarter.
- 9 funds opened new Cerenome positions in Q2 2026 and 10 closed out, a net change of -1 holder.
- The largest Cerenome buyer in Q2 2026 was Vanguard Capital Management, an estimated $1.13M added.
- The largest Cerenome seller in Q2 2026 was Vanguard Fiduciary Trust, an estimated $52.8K sold.
Based on aggregated 13F filings for Q2 2026.